4506Sumitomo Pharma Co.,Ltd.¥ --

Sumitomo Pharma Co.,Ltd.

4506

TSE PrimePharmaceuticals

¥ -

Sumitomo Pharma Co.,Ltd. (4506) statement of comprehensive income, including other comprehensive income and total comprehensive income.

The statement of comprehensive income shows net income alongside other comprehensive income, including currency translation and changes in asset values.

Statement of Comprehensive Income Details

IFRS　Unit: JPY

Item

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

Profit/Loss

Net gain (loss) on revaluation of financial assets measured at fair value through other comprehensive income

Remeasurements of Defined Benefit Plans (OCI)

Net gain (loss) on revaluation of financial assets measured at fair value through other comprehensive income (net of tax)

Foreign Currency Translation Adjustment (OCI)

Total Other Comprehensive Income

Comprehensive Income

Comprehensive Income Attributable to Owners of Parent

106.9B

1.2B

3.5B

58.0M

11.3B

16.1B

123.0B

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan